Tuesday’s one-hour webinar is entitled “Covering Prescription Digital Therapeutics: A Win-Win for Employers and Employees.” The program will explore the FDA clearance process for digital therapies, how the products enhance health care, and how employers can add PDTs to their formularies. Panelists will provide examples of how PDTs can improve employee health and productivity, enhance health equity, and reduce employers’ costs.
The webinar meets the continuing education requirements for the Society for Human Resource Management (SHRM) and the HR Certification Institute. HR professionals can earn one hour of credit by participating.
The webinar builds upon recent coalition efforts to educate policy makers on the need for patient access to PDTs. We March 25Aimed Alliance, the Center for US Policy, and 31 other not-for-profit organizations sent a letter to commend Members of Congress for introducing legislation that would provide Medicare coverage and create a new Medicaid payment category for PDTs.
The bipartisan ”Access to Prescription Digital Therapeutics Act of 2022” (S. 3791 and HR 7051) is sponsored by Sens. Jeanne Shaheen (NH) and Shelley MooreCapito (WV), and Reps. mike thompson (CA-5) and David McKinley (WV-01).
“We support this legislation as it expands access to innovative therapeutics for patients, and we encourage Congress to swiftly adopt this bill and to create a new Medicaid payment category for PDTs,” the letter read.
SOURCE Center for US Policy